Skip to content
Screener

Medtronic MDT Cardiovascular — Reportable segment operating profit

Other segment segments

Neuroscience
$879M+2.4%
Medical Surgical
$605M+5.2%
Diabetes
$57M+14.0%
Other operating segment
-$1M-108%

Similar metrics at other companies

California Resources logo
CRCTotal Reportable Segments — Segment profit or (loss)
$270M+12.0%
ARE
AREReportable Segment, Aggregation before Other Operating Segment — Reportable segment net operating income (reportable segment profit or loss)
$413.14M-16.2%
Elevance Health logo
ELVCarelonRx Segment — Reportable segments’ operating gain
$582M+8.6%
Designer Brands logo
DBIRetail — Segment operating profit
$51.28M+28.3%
United Parcel Service, Inc. logo
UPSInternational Segment — Operating profit
$623M-7.3%
LCI Industries logo
LCIIAftermarket Segment — Operating profit
$51.88M+43.6%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$110.07B-3.9%
Enterprise value$137.33B-3.2%
P/E22.9×-1.6×
P/S3×-0.3×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Medtronic’s 10-K, filed June 18, 2026.

Filed
Jun 18, 2026, 4:27 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-044354
(in millions)CardiovascularNeuroscienceMedical SurgicalTotal
Research and development expense1,1366166862,438
Selling, general, and administrative expense4,5193,4212,51110,451
Other segment items(3)(46)36144
Reportable segment operating profit$3,672$3,062$2,128$8,862
Reconciliation of segment profit / (loss)
Other operating segments profit(1)106
Currency and other(112)
Interest expense, net(715)

Item 8. Financial Statements and Supplementary Data

FAQ

What is Medtronic's cardiovascular — reportable segment operating profit?
Medtronic (MDT) reported cardiovascular — reportable segment operating profit of $1.07B in Q1 2026.
How has Medtronic's cardiovascular — reportable segment operating profit changed year-over-year?
Medtronic's cardiovascular — reportable segment operating profit increased by 11.8% year-over-year, from $955M to $1.07B.
What is the long-term trend for Medtronic's cardiovascular — reportable segment operating profit?
Over 4 years (2022 to 2026), Medtronic's cardiovascular — reportable segment operating profit has grown at a -5.5% compound annual growth rate (CAGR), from $4.6B to $3.67B.
What does cardiovascular — reportable segment operating profit mean?
This metric represents the operating income generated by the cardiovascular segment after deducting direct operating expenses from net sales. It serves as the primary measure of the segment's profitability and operational efficiency. It excludes corporate-level overheads and interest expenses to isolate the performance of the cardiovascular business unit.

Ask your AI about Medtronic's cardiovascular — reportable segment operating profit.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude